Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RADX compared with CRIS: revenue, margins and what each company keeps, and the suppliers and customers both name
RADX
Radiopharm Theranostics Ltd
Change
Mkt cap
Revenue
Revenue
CRIS
Curis Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
RADX
Radiopharm Theranostics Ltd
vs
CRIS
Curis Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RADX
3
—
AtomVie
unlisted
supplier
—
Diaprost AB
unlisted
supplier
—
Lantheus
unlisted
customer
Shared
0
No shared counterparties.
Only CRIS
1
—
Genentech
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
RADX
Radiopharm Theranostics Ltd
Change
1.04
▲
+16.99%
· post 1.03
Mkt cap
$3.4B
Revenue
—
Revenue
—
CRIS
Curis Inc
Change
0.88
▲
+3.29%
· post 0.80
Closed
Nov 6 '26
Mkt cap
$1.9M
Revenue
$1M
Q4 FY25
Revenue
$9M
FY25
vs
Compare
Closed
Nov 6 '26
RADX
Radiopharm Theranostics Ltd
vs
CRIS
Curis Inc
1.04
▲
+16.99%
post 1.03
Price
0.88
▲
+3.29%
post 0.80
$3.4B
Mkt cap
$1.9M
—
Revenue
$1M
Q4 FY25
—
Revenue
$9M
FY25
Change
Change
RADX
1.04
▲
+16.99%
vs
CRIS
0.88
▲
+3.29%
Closed
Nov 6 '26